Kelekçi Simge, Yıldız Abdullah Burak, Sevinç Kenan, Çimen Deniz Uğurlu, Önder Tamer
School of Medicine, Koc University, Istanbul, Turkey.
Front Cell Dev Biol. 2022 Aug 11;10:958398. doi: 10.3389/fcell.2022.958398. eCollection 2022.
Friedreich's ataxia (FRDA, OMIM#229300) is the most common hereditary ataxia, resulting from the reduction of frataxin protein levels due to the expansion of GAA repeats in the first intron of the gene. Why the triplet repeat expansion causes a decrease in Frataxin protein levels is not entirely known. Generation of effective FRDA disease models is crucial for answering questions regarding the pathophysiology of this disease. There have been considerable efforts to generate and models of FRDA. In this perspective article, we highlight studies conducted using FRDA animal models, patient-derived materials, and particularly induced pluripotent stem cell (iPSC)-derived models. We discuss the current challenges in using FRDA animal models and patient-derived cells. Additionally, we provide a brief overview of how iPSC-based models of FRDA were used to investigate the main pathways involved in disease progression and to screen for potential therapeutic agents for FRDA. The specific focus of this perspective article is to discuss the outlook and the remaining challenges in the context of FRDA iPSC-based models.
弗里德赖希共济失调(FRDA,OMIM编号#229300)是最常见的遗传性共济失调,由于该基因第一个内含子中GAA重复序列的扩增导致frataxin蛋白水平降低所致。三联体重复序列扩增为何会导致frataxin蛋白水平降低尚不完全清楚。建立有效的FRDA疾病模型对于回答有关该疾病病理生理学的问题至关重要。人们已经付出了巨大努力来建立FRDA的动物模型和细胞模型。在这篇观点文章中,我们重点介绍了使用FRDA动物模型、患者来源材料,特别是诱导多能干细胞(iPSC)衍生模型所进行的研究。我们讨论了使用FRDA动物模型和患者来源细胞目前面临的挑战。此外,我们简要概述了基于iPSC的FRDA模型如何用于研究疾病进展所涉及的主要途径以及筛选FRDA的潜在治疗药物。这篇观点文章的具体重点是讨论基于FRDA iPSC模型的前景和剩余挑战。